| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/00004836-200211002-00002 |
| P698 | PubMed publication ID | 12394209 |
| P50 | author | Hashem El-Serag | Q5678908 |
| P433 | issue | 5 Suppl 2 | |
| P921 | main subject | epidemiology | Q133805 |
| hepatocellular carcinoma | Q1148337 | ||
| P304 | page(s) | S72-8 | |
| P577 | publication date | 2002-11-01 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Journal of Clinical Gastroenterology | Q15710046 |
| P1476 | title | Hepatocellular carcinoma: an epidemiologic view | |
| P478 | volume | 35 |
| Q40279228 | 17 Beta-estradiol prevents cytotoxicity from hydrophobic bile acids in HepG2 and WRL-68 cell cultures |
| Q35859035 | 5-Fluorouracil concentration in blood, liver and tumor tissues and apoptosis of tumor cells after preoperative oral 5'-deoxy-5-fluorouridine in patients with hepatocellular carcinoma |
| Q47369710 | A Comparative Analysis of Hepatocellular Carcinoma after Hepatic Resection in Young versus Elderly Patients |
| Q42433365 | A case of necrotizing pancreatitis subsequent to transcatheter arterial chemoembolization in a patient with hepatocellular carcinoma. |
| Q42149608 | A cell-permeable hairpin peptide inhibits hepatitis C viral nonstructural protein 5A-mediated translation and virus production |
| Q54216177 | A disintegrin and metalloprotease (ADAM)10 is highly expressed in hepatocellular carcinoma and is associated with tumour progression |
| Q38975201 | A novel oleanolic acid-loaded PLGA-TPGS nanoparticle for liver cancer treatment |
| Q35172998 | A survey on herbal management of hepatocellular carcinoma |
| Q39459780 | Aberrant expression of microRNA 155 may accelerate cell proliferation by targeting sex-determining region Y box 6 in hepatocellular carcinoma. |
| Q36803472 | Allosteric heat shock protein 70 inhibitors block hepatitis C virus assembly |
| Q35954415 | Altered p-STAT3 (tyr705) expression is associated with histological grading and intratumour microvessel density in hepatocellular carcinoma |
| Q28237169 | An integrated data analysis approach to characterize genes highly expressed in hepatocellular carcinoma |
| Q33762901 | Analysis of serum haptoglobin fucosylation in hepatocellular carcinoma and liver cirrhosis of different etiologies |
| Q38723615 | Anti-HBV Activities of Three Compounds Extracted and Purified from Herpetospermum Seeds |
| Q39041125 | Antioxidant and cytotoxic activity of polyphenolic compounds isolated from the leaves ofLeucenia leucocephala |
| Q36425910 | Antitumor activity of type I and type III interferons in BNL hepatoma model |
| Q40241047 | Apoptotic and anti-proliferative effects of 17beta-estradiol and 17beta-estradiol-like compounds in the Hep3B cell line |
| Q46099165 | Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma. |
| Q64974192 | Association between polymorphisms in MicroRNA target sites of RAD51D genes and risk of hepatocellular carcinoma. |
| Q34555080 | Association of Helicobacter species with hepatitis C cirrhosis with or without hepatocellular carcinoma |
| Q43058852 | Association of circulating insulin-like growth factor 1 with hepatocellular carcinoma: one cross-sectional correlation study. |
| Q33302500 | Association of mortalin (HSPA9) with liver cancer metastasis and prediction for early tumor recurrence. |
| Q50691486 | B vitamins deficiency and decreased anti-oxidative state in patients with liver cancer |
| Q36337903 | Bid-overexpression regulates proliferation and phosphorylation of Akt and MAPKs in response to etoposide-induced DNA damage in hepatocellular carcinoma cells |
| Q45059708 | Both de novo synthetized and exogenous fatty acids support the growth of hepatocellular carcinoma cells. |
| Q40359283 | Brain metastases from hepatocellular carcinoma in US patients |
| Q35056621 | Brain metastasis from hepatocellular carcinoma: the role of surgery as a prognostic factor |
| Q33786347 | CD133+ liver cancer stem cells from methionine adenosyl transferase 1A-deficient mice demonstrate resistance to transforming growth factor (TGF)-beta-induced apoptosis |
| Q45913435 | CT prediction of histological grade of hypervascular hepatocellular carcinoma: utility of the portal phase. |
| Q24812191 | Cancer incidence in the south Asian population of California, 1988-2000. |
| Q45966861 | Cancer-associated molecular signature in the tissue samples of patients with cirrhosis. |
| Q35545730 | Casticin-induced apoptosis involves death receptor 5 upregulation in hepatocellular carcinoma cells |
| Q33688897 | Celecoxib suppresses hepatoma stemness and progression by up-regulating PTEN. |
| Q36613652 | Changes in the serum proteome associated with the development of hepatocellular carcinoma in hepatitis C-related cirrhosis |
| Q88581876 | Changing Paradigm in the Surgical Management of Hepatocellular Carcinoma With Salvage Transplantation |
| Q37777019 | Chromosome 1q21 amplification and oncogenes in hepatocellular carcinoma. |
| Q41886998 | Chromosome alterations in human hepatocellular carcinomas correlate with aetiology and histological grade--results of an explorative CGH meta-analysis |
| Q36011412 | Circulating Tumor Cells Measurements in Hepatocellular Carcinoma |
| Q41921235 | Circulating microRNA, miR-122 and miR-221 signature in Egyptian patients with chronic hepatitis C related hepatocellular carcinoma. |
| Q36884764 | Circulating microRNA-122a as a diagnostic marker for hepatocellular carcinoma |
| Q39441537 | Clinical characteristics and time trends in etiology of hepatocellular cancer in Germany |
| Q44038010 | Clinical features and prognosis of hepatocellular carcinoma in Mongolia: a multicentre study. |
| Q54459170 | Clinical implications of deregulated CDK4 and Cyclin D1 expression in patients with human hepatocellular carcinoma |
| Q44971520 | Clinicopathological Features and Outcomes of Young Patients with Hepatocellular Carcinoma after Hepatectomy |
| Q36190517 | Colchicine sensitizes human hepatocellular carcinoma cells to damages caused by radiation |
| Q33393386 | Community‐based screening for hepatocellular carcinoma in elderly residents in a hepatitis B‐ and C‐endemic area |
| Q36178891 | Comparison between chemoembolization combined with radiotherapy and chemoembolization alone for large hepatocellular carcinoma |
| Q46050521 | Comparison between living donor liver transplantation recipients who met the Milan and UCSF criteria after successful downstaging therapies |
| Q51875306 | Comparison of the outcomes of patients who underwent deceased-donor or living-donor liver transplantation after successful downstaging therapy |
| Q64079380 | Core fucosylated glycan-dependent inhibitory effect of QSOX1-S on invasion and metastasis of hepatocellular carcinoma |
| Q51773097 | Correlation between imaging and pathologic findings in explanted livers of hepatocellular carcinoma cases. |
| Q47332395 | Correlation between the radiologic and histologic size of hepatocellular carcinoma in patients eligible for liver transplantation |
| Q45889426 | Correlation of CpG island methylator phenotype with poor prognosis in hepatocellular carcinoma |
| Q36911277 | Cost-effectiveness of sorafenib versus SBRT for unresectable advanced hepatocellular carcinoma |
| Q36345195 | Coupled down-regulation of mTOR and telomerase activity during fluorouracil-induced apoptosis of hepatocarcinoma cells |
| Q55717970 | Definitive locoregional therapy (LRT) versus bridging LRT and liver transplantation with wait-and-not-treat approach for very early stage hepatocellular carcinoma. |
| Q34064365 | Detection and characterization of liver lesions using gadoxetic acid as a tissue-specific contrast agent |
| Q35007172 | Detection of hepatocellular carcinoma in hepatitis C patients: biomarker discovery by LC-MS. |
| Q60936575 | Development of asialoglycoprotein receptor directed nanoparticles for selective delivery of curcumin derivative to hepatocellular carcinoma |
| Q30490554 | Diagnosis of hepatocellular carcinoma. |
| Q40499918 | Diagnostic and prognostic roles of serum vitronectin in hepatitis B-related hepatocellular carcinoma |
| Q36373621 | Differential Proteomic Analysis of Gender-dependent Hepatic Tumorigenesis in Hras12V Transgenic Mice |
| Q51538104 | Diffusion-weighted imaging of hepatocellular carcinomas: a retrospective analysis of correlation between apparent diffusion coefficients and histological grade. |
| Q39279264 | Divergent antiviral effects of bioflavonoids on the hepatitis C virus life cycle |
| Q38611484 | Does pyogenic liver abscess increase the risk of delayed-onset primary liver cancer?: Evidence from a nationwide cohort study |
| Q83856045 | Downregulation of GRIM-19 is associated with hyperactivation of p-STAT3 in hepatocellular carcinoma |
| Q50244060 | Downstaging Advanced Hepatocellular Carcinoma to the Milan Criteria May Provide a Comparable Outcome to Conventional Milan Criteria |
| Q36519010 | Dysregulation of growth factor signaling in human hepatocellular carcinoma. |
| Q39923417 | ERK5 is a target for gene amplification at 17p11 and promotes cell growth in hepatocellular carcinoma by regulating mitotic entry |
| Q34998414 | Effect and safety of interferon for hepatocellular carcinoma: a systematic review and meta-analysis |
| Q34771239 | Effect of Oral Supplementation with Branched-chain Amino Acid (BCAA) during Radiotherapy in Patients with Hepatocellular Carcinoma: A Double-Blind Randomized Study |
| Q35925833 | Effect of ultrasound-guided radiofrequency ablation in incompletely treated hepatocellular carcinoma after transcatheter arterial chemoembolization |
| Q42283822 | Effective therapeutic management of hepatocellular carcinoma - on the basis of a clinical case |
| Q54213480 | Efficacy and safety of sofosbuvir plus daclatasvir with or without ribavirin: large real-life results of patients with chronic hepatitis C genotype 4. |
| Q37300543 | Elevated liver fibrosis index FIB-4 is not reliable for HCC risk stratification in predominantly non-Asian CHB patients |
| Q38109962 | Epidemiological characteristics of hepatocellular carcinoma in Egypt: a retrospective analysis of 1313 cases |
| Q36454765 | Epidemiological pattern of hepatitis B and hepatitis C as etiological agents for hepatocellular carcinoma in iran and worldwide |
| Q34589304 | Epidemiology and carcinogenesis of hepatocellular carcinoma |
| Q34563350 | Epidemiology of Primary and Secondary Liver Cancers |
| Q36519002 | Epidemiology of hepatocellular carcinoma in areas of low hepatitis B and hepatitis C endemicity |
| Q53697334 | Epidemiology of liver cancer in Nile delta over a decade: A single-center study. |
| Q33820694 | Epigenetic regulation of cancer stem cell marker CD133 by transforming growth factor-beta |
| Q39144192 | Estrogen receptor α (ESR1) over-expression mediated apoptosis in Hep3B cells by binding with SP1 proteins |
| Q26800232 | Evaluation of a Proposed Biodegradable 188Re Source for Brachytherapy Application: A Review of Dosimetric Parameters |
| Q39847276 | Expansion of CD133-expressing liver cancer stem cells in liver-specific phosphatase and tensin homolog deleted on chromosome 10-deleted mice |
| Q57149606 | Expression of bile duct transcription factor HNF1β predicts early tumor recurrence and is a stage-independent prognostic factor in hepatocellular carcinoma |
| Q34808766 | Factors Associated with Compliance with Recommendations for Liver Cancer Screening in Korea: A Nationwide Survey in Korea |
| Q37178560 | Frequency of elevated biomarkers in patients with cryptogenic hepatocellular carcinoma |
| Q36067465 | Gender difference in clinicopathologic features and survival of patients with hepatocellular carcinoma |
| Q37278203 | Gender-based outcomes differences in unresectable hepatocellular carcinoma |
| Q33380441 | Genetic profile of Egyptian hepatocellular-carcinoma associated with hepatitis C virus Genotype 4 by 15 K cDNA microarray: preliminary study |
| Q35507447 | Genotypes, mutations, and viral load of hepatitis B virus and the risk of hepatocellular carcinoma: HBV properties and hepatocarcinogenesis |
| Q91936298 | Global scientific trends on aflatoxin research during 1998-2017: a bibliometric and visualized study |
| Q37476963 | Gut microbes define liver cancer risk in mice exposed to chemical and viral transgenic hepatocarcinogens. |
| Q59350577 | HCV-Specific T Cell Responses During and After Chronic HCV Infection |
| Q44176126 | Health-related quality of life in patients with hepatocellular carcinoma: the mediation effects of illness perceptions and coping |
| Q37114166 | Helicobacter species and liver diseases: association or causation? |
| Q84273641 | Hepatic resection for huge (>15 cm) multinodular HCC with macrovascular invasion |
| Q36844469 | Hepatitis B and C viruses and survival from hepatocellular carcinoma in the Arkhangelsk region: a Russian registry-based study |
| Q35045196 | Hepatitis B and alcohol affect survival of hepatocellular carcinoma patients |
| Q42270372 | Hepatitis C Genotypes in Libya: Correlation with Patients' Characteristics, Level of Viremia, and Degree of Liver Fibrosis |
| Q36971067 | Hepatitis C virus (HCV): an RNA virus with a pro-oncogenic potential. |
| Q24339370 | Hepatitis C virus NS5A protein interacts with phosphatidylinositol 4-kinase type IIIalpha and regulates viral propagation |
| Q37399410 | Hepatitis C virus drives the pathogenesis of hepatocellular carcinoma: from immune evasion to carcinogenesis. |
| Q39409500 | Hepatocellular and Cholangiolar Carcinoma-Derived Cell Lines Reveal Distinct Sets of Chromosomal Imbalances |
| Q88881082 | Hepatocellular carcinoma - an unusual metastatic presentation on the chest wall |
| Q35059721 | Hepatocellular carcinoma in Egypt: a single center study over a decade. |
| Q34134967 | Hepatocellular carcinoma in the world and the middle East |
| Q45247507 | Hepatocellular carcinoma patients with increased oxidative stress levels are prone to recurrence after curative treatment: a prospective case series study using the d-ROM test |
| Q33590801 | Hepatopoietin Cn suppresses apoptosis of human hepatocellular carcinoma cells by up-regulating myeloid cell leukemia-1. |
| Q53013310 | High ATF5 expression is a favorable prognostic indicator in patients with hepatocellular carcinoma after hepatectomy |
| Q54200791 | High STAT4 expression is a better prognostic indicator in patients with hepatocellular carcinoma after hepatectomy. |
| Q41135024 | Histone-modifying genes as biomarkers in hepatocellular carcinoma |
| Q64226373 | Homeostatic Model Assessment of Insulin Resistance for Predicting the Recurrence of Hepatocellular Carcinoma after Curative Treatment |
| Q40403286 | Human Schistosomiasis mansoni associated with hepatocellular carcinoma in Egypt: current perspective |
| Q38183539 | Hydrodynamic transfection for generation of novel mouse models for liver cancer research |
| Q64064212 | INPP4B inhibits cell proliferation, invasion and chemoresistance in human hepatocellular carcinoma |
| Q92605647 | Identification of crucial genes based on expression profiles of hepatocellular carcinomas by bioinformatics analysis |
| Q39474516 | Identification of the IFITM3 gene as an inhibitor of hepatitis C viral translation in a stable STAT1 cell line |
| Q37370024 | Image-guided percutaneous ablation therapies for hepatocellular carcinoma |
| Q53466302 | Imaging nodules within cirrhotic liver: how do I do it? |
| Q87535423 | Immunohistochemical Study of Glypican-3 and HepPar-1 in Differentiating Hepatocellular Carcinoma from Metastatic Carcinomas in FNA of the Liver |
| Q41511393 | Impact of IL28B and PNPLA3 polymorphisms on treatment outcomes in patients infected with genotype 6 hepatitis C virus |
| Q33728605 | Impact of metronomic UFT/cyclophosphamide chemotherapy and antiangiogenic drug assessed in a new preclinical model of locally advanced orthotopic hepatocellular carcinoma |
| Q37229285 | In search of liver cancer stem cells. |
| Q54271311 | Incidence and management of hepatocellular carcinoma among Māori and non-Māori New Zealanders |
| Q37270948 | Incidence and risk factors for hepatocellular carcinoma after solid organ transplantation |
| Q36848284 | Incidence, endoscopic morphology and distribution of metastatic lesions in the gastrointestinal tract |
| Q35522278 | Increased levels of serum leptin are a risk factor for the recurrence of stage I/II hepatocellular carcinoma after curative treatment |
| Q55261967 | Increased visceral fat volume raises the risk for recurrence of hepatocellular carcinoma after curative treatment. |
| Q38061619 | Influence of age and gender before and after liver transplantation |
| Q33962378 | Inhibition of Aurora-B suppresses HepG2 cell invasion and migration via the PI3K/Akt/NF-κB signaling pathway in vitro |
| Q89909200 | Integrative module analysis of HCC gene expression landscapes |
| Q21296797 | Interferon Lambda: A New Sword in Cancer Immunotherapy |
| Q40712723 | Interleukin-28B TT genotype is frequently found in patients with hepatitis C virus cirrhosis but does not influence hepatocarcinogenesis |
| Q55633244 | Inverse Association between Glucose‒6‒Phosphate Dehydrogenase Deficiency and Hepatocellular Carcinoma |
| Q38078075 | Irreversible electroporation for unresectable hepatocellular carcinoma: initial experience and review of safety and outcomes. |
| Q35864469 | Isoflavones-Enriched Soy Protein Prevents CCL(4)-Induced Hepatotoxicity in Rats |
| Q38885249 | Lentivirus mediated silencing of ubiquitin specific peptidase 39 inhibits cell proliferation of human hepatocellular carcinoma cells in vitro |
| Q33903328 | Little response of cerebral metastasis from hepatocellular carcinoma to any treatments |
| Q35615755 | Liver angiogenesis as a risk factor for hepatocellular carcinoma development in hepatitis C virus cirrhotic patients. |
| Q43948092 | Liver cancer and hepatitis B and C in New South Wales, 1990-2002: a linkage study |
| Q45905963 | Liver cirrhosis in Malaysia: peculiar epidemiology in a multiracial Asian country. |
| Q36448689 | Liver resection in the treatment of hepatocellular carcinoma |
| Q37458352 | Liver transplantation in the ethnic minority population: challenges and prospects |
| Q82845317 | Liver transplantation, liver resection, and transarterial chemoembolization for hepatocellular carcinoma in cirrhosis: which is the best oncological approach? |
| Q35921769 | Liver-targeting Resibufogenin-loaded poly(lactic-co-glycolic acid)-D-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles for liver cancer therapy. |
| Q43648648 | Long-term interferon maintenance therapy improves survival in patients with HCV-related hepatocellular carcinoma after curative radiofrequency ablation. A matched case-control study |
| Q45010628 | Long-term outcomes and prognostic factors of elderly patients with hepatocellular carcinoma undergoing hepatectomy |
| Q36528511 | Longitudinal metabolic imaging of hepatocellular carcinoma in transgenic mouse models identifies acylcarnitine as a potential biomarker for early detection |
| Q54514227 | Loss of 13q is associated with genes involved in cell cycle and proliferation in dedifferentiated hepatocellular carcinoma |
| Q35872096 | Loss of Wnt5a and Ror2 protein in hepatocellular carcinoma associated with poor prognosis |
| Q44097379 | Management and treatment of hepatitis C viral infection: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center program and the National Hepatitis C Program office |
| Q87664325 | Management of hepatocellular carcinoma |
| Q45143067 | Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults |
| Q35828338 | Microarray profiling shows distinct differences between primary tumors and commonly used preclinical models in hepatocellular carcinoma. |
| Q46419685 | Molecular mechanisms of nano-selenium in mitigating hepatocellular carcinoma induced by N-nitrosodiethylamine (NDEA) in rats. |
| Q52583955 | Molecular signatures in hepatocellular carcinoma: A step toward rationally designed cancer therapy. |
| Q36871711 | Multicenter italian experience in liver transplantation for hepatocellular carcinoma in HIV-infected patients |
| Q36790704 | National trends and disparities in the incidence of hepatocellular carcinoma, 1998-2003. |
| Q46675149 | Natural history of untreated nonsurgical hepatocellular carcinoma |
| Q34653639 | Non-viral factors contributing to hepatocellular carcinoma |
| Q45153118 | Non‐alcoholic fatty liver disease contributes to hepatocarcinogenesis in non‐cirrhotic liver: A clinical and pathological study |
| Q34677661 | Occult HBV infection among Egyptian hepatocellular carcinoma patients. |
| Q42573914 | Octreotide induces caspase activation and apoptosis in human hepatoma HepG2 cells. |
| Q35660038 | Optimal adjuvant therapy for resected hepatocellular carcinoma: a systematic review with network meta-analysis |
| Q79434802 | Overexpression of NDRG1 is an indicator of poor prognosis in hepatocellular carcinoma |
| Q46120182 | Overexpression of Thy1/CD90 in human hepatocellular carcinoma is associated with HBV infection and poor prognosis |
| Q37453166 | Overexpression of endothelin 1 triggers hepatocarcinogenesis in zebrafish and promotes cell proliferation and migration through the AKT pathway |
| Q92316075 | PTEN Tumor-Suppressor: The Dam of Stemness in Cancer |
| Q36430423 | Pathogen-driven gastrointestinal cancers: Time for a change in treatment paradigm? |
| Q36208355 | Patterns of treatment and costs of intermediate and advanced hepatocellular carcinoma management in four Italian centers |
| Q38261930 | Plasma DCLK1 is a marker of hepatocellular carcinoma (HCC): Targeting DCLK1 prevents HCC tumor xenograft growth via a microRNA-dependent mechanism. |
| Q46347889 | Polyol profile as an early diagnostic and prognostic marker in natural product chemoprevention of hepatocellular carcinoma in diabetic rats |
| Q36065568 | Postoperative adjuvant arterial chemoembolization improves survival of hepatocellular carcinoma patients with risk factors for residual tumor: a retrospective control study |
| Q38331590 | Potent induction of apoptosis in human hepatoma cell lines by targeted cytotoxic somatostatin analogue AN-238. |
| Q99608961 | Potential biomarkers Ang II/AT1R and S1P/S1PR1 predict the prognosis of hepatocellular carcinoma |
| Q35770282 | Potential role of leptin expression in hepatocellular carcinoma |
| Q87231042 | Prediction of postoperative complications in elderly patients with hepatocellular carcinoma |
| Q37130713 | Preoperative alpha-fetoprotein slope is predictive of hepatocellular carcinoma recurrence after liver transplantation |
| Q36230527 | Prevalence of type 2 diabetes mellitus in Japanese patients with hepatocellular carcinoma |
| Q44495220 | Primary liver cancer incidence among American Indians and Alaska Natives, US, 1999-2004. |
| Q38464518 | Primary versus salvage living donor liver transplantation for patients with hepatocellular carcinoma: impact of microvascular invasion on survival |
| Q42182106 | Progesterone and related compounds in hepatocellular carcinoma: basic and clinical aspects. |
| Q43693428 | Prognostic impact of underlying liver fibrosis and cirrhosis after curative resection of hepatocellular carcinoma |
| Q37463744 | Prognostic role of vascular endothelial growth factor in hepatocellular carcinoma: systematic review and meta-analysis |
| Q33594879 | Pros and cons of liver transplantation in human immunodeficiency virus infected recipients |
| Q37577536 | Protective effects of higher cognitive reserve for neuropsychological and daily functioning among individuals infected with hepatitis C |
| Q48800400 | Pyogenic Liver Abscess as the Initial Manifestation of Underlying Hepatocellular Carcinoma |
| Q38056630 | Quality Improvement Measures Lead to Higher Surveillance Rates for Hepatocellular Carcinoma in Patients with Cirrhosis |
| Q33911988 | Quantitative 4D transcatheter intraarterial perfusion MRI for monitoring chemoembolization of hepatocellular carcinoma |
| Q81800830 | R0 liver resections for primary malignant liver tumors in the noncirrhotic liver: a diagnosis-related analysis |
| Q35707523 | RNAa-mediated overexpression of WT1 induces apoptosis in HepG2 cells |
| Q36798116 | Racial/Ethnic Disparities in Consistent Reporting of Smoking-Related Behaviors |
| Q46443339 | Radiation dose reduction in hepatic multidetector computed tomography with a novel adaptive noise reduction filter |
| Q37113543 | Radioembolization for the treatment of unresectable hepatocellular carcinoma: a clinical review |
| Q82258567 | Radiofrequency ablation for hepatocellular carcinoma: a survival analysis of 117 patients |
| Q37296885 | Radiofrequency ablation is superior to ethanol injection in early-stage hepatocellular carcinoma irrespective of tumor size |
| Q46755959 | Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC). |
| Q44453052 | Radiological response predicts survival following transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma. |
| Q92731008 | Rapid Depletions of Subcutaneous Fat Mass and Skeletal Muscle Mass Predict Worse Survival in Patients with Hepatocellular Carcinoma Treated with Sorafenib |
| Q30986337 | Rapid induction of orthotopic hepatocellular carcinoma in immune-competent rats by non-invasive ultrasound-guided cells implantation |
| Q24548312 | Reactive oxygen species: role in the development of cancer and various chronic conditions |
| Q34882348 | Recent advances in cancer vaccines: an overview |
| Q39033112 | Recombinant adenovirus encoding FAT10 small interfering RNA inhibits HCC growth in vitro and in vivo |
| Q50481283 | Reduced organic anion transporter expression is a risk factor for hepatocellular carcinoma in chronic hepatitis C patients: a propensity score matching study |
| Q51691419 | Reduced transforming growth factor-beta receptor II expression in hepatocellular carcinoma correlates with intrahepatic metastasis |
| Q36386685 | Relationship of α-fetoprotein levels and development of hepatocellular carcinoma in hepatitis C patients with liver cirrhosis |
| Q42993328 | Risk Factors and Incidence of Hepatocellular Carcinoma in Southeast Iran |
| Q35809855 | Risk Factors of Cryptogenic Hepatocellular Carcinoma in Patients with Low Body Mass Index or without Metabolic Syndrome |
| Q48014304 | Role of Diffusion Weighted Imaging (DWI) for Hepatocellular Carcinoma (HCC) Detection and its Grading on 3T MRI: A Prospective Study |
| Q37065772 | Role of cyclin D1 as a mediator of c-Met- and beta-catenin-induced hepatocarcinogenesis |
| Q63641946 | Role of p53 and β-catenin Mutations in Conjunction with CK19 Expression on Early Tumor Recurrence and Prognosis of Hepatocellular Carcinoma |
| Q37183205 | Role of radiofrequency ablation in unresectable hepatocellular carcinoma: An Indian experience |
| Q38315152 | SNPs in the promoter region of the osteopontin gene as a possible host factor for sex difference in hepatocellular carcinoma development in patients with HCV. |
| Q43772344 | Safety and effectiveness of repeat arterial closure using the StarClose vascular closure device in patients with hepatic malignancy |
| Q41233079 | Safety assessment and therapeutic efficacy of percutaneous microwave ablation therapy combined with percutaneous ethanol injection for hepatocellular carcinoma adjacent to the gallbladder |
| Q36059063 | Screening for hepatocellular carcinoma by Egyptian physicians |
| Q35594964 | Screening for hepatocellular carcinoma in cirrhosis |
| Q82627208 | Seroprevalence of anti-HCV among patients with oral lichen planus in Southern Taiwan |
| Q42528372 | Serum N-glycome biomarker for monitoring development of DENA-induced hepatocellular carcinoma in rat. |
| Q36411874 | Serum miR-96 is a promising biomarker for hepatocellular carcinoma in patients with chronic hepatitis B virus infection |
| Q88379422 | Short-Term Outcomes following Hepatectomy in Elderly Patients with Hepatocellular Carcinoma: An Analysis of 10,805 Septuagenarians and 2,381 Octo- and Nonagenarians in Japan |
| Q30988387 | Significance of Aurora B overexpression in hepatocellular carcinoma. Aurora B Overexpression in HCC. |
| Q59349628 | Significance of Glypican-3 in Early Detection of Hepatocellular Carcinoma in Cirrhotic Patients |
| Q51736029 | Skeletal muscle depletion is an independent prognostic factor for hepatocellular carcinoma |
| Q35722941 | Skeletal muscle depletion predicts the prognosis of patients with hepatocellular carcinoma treated with sorafenib |
| Q34022318 | Snail1 induces epithelial-to-mesenchymal transition and tumor initiating stem cell characteristics |
| Q36502739 | Spontaneous acute epidural hematoma developed due to skull metastasis of hepatocelluar carcinoma: A case report and review of the literature |
| Q38933346 | Structural characterization of the HSP70 interaction domain of the hepatitis C viral protein NS5A. |
| Q50133914 | Subclassification and Detection of New Markers for the Discrimination of Primary Liver Tumors by Gene Expression Analysis Using Oligonucleotide Arrays |
| Q38769255 | Surgical resection of localized hepatocellular carcinoma: patient selection and special consideration |
| Q34469509 | Surgicalvspercutaneous radiofrequency ablation for hepatocellular carcinoma in dangerous locations |
| Q36812480 | Surveillance and Diagnosis of Hepatocellular Carcinoma |
| Q58033116 | Survival after diagnosis of hepatocellular carcinoma and potential impact of treatment in a hepatitis B or C infected cohort |
| Q47153666 | Survival benefit of radiofrequency ablation for solitary (3-5 cm) hepatocellular carcinoma: An analysis for nationwide cancer registry |
| Q92592424 | Sustained virological response by direct-acting antivirals reduces the recurrence risk of hepatitis C-related hepatocellular carcinoma after curative treatment |
| Q36827264 | Systematic Analysis of Enhancer and Critical cis -Acting RNA Elements in the Protein-Encoding Region of the Hepatitis C Virus Genome |
| Q33964077 | Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma |
| Q33913779 | Systematic review of outcome of downstaging hepatocellular cancer before liver transplantation in patients outside the Milan criteria. |
| Q38755671 | Systemic transcriptome analysis of hepatocellular carcinoma |
| Q59382358 | Telomere shortening correlates with increasing aneuploidy of chromosome 8 in human hepatocellular carcinoma |
| Q36195572 | Ten-Year Changes in the Hepatitis B Prevalence in the Birth Cohorts in Korea: Results From Nationally Representative Cross-Sectional Surveys |
| Q26863635 | Th1/Th2 cytokines and their genotypes as predictors of hepatitis B virus related hepatocellular carcinoma |
| Q35636713 | The EGFR/ErbB3 Pathway Acts as a Compensatory Survival Mechanism upon c-Met Inhibition in Human c-Met+ Hepatocellular Carcinoma. |
| Q39277756 | The NS5A-binding heat shock proteins HSC70 and HSP70 play distinct roles in the hepatitis C viral life cycle |
| Q46970742 | The combinational effect of vincristine and berberine on growth inhibition and apoptosis induction in hepatoma cells |
| Q37354782 | The heat shock protein inhibitor Quercetin attenuates hepatitis C virus production |
| Q39560212 | The homeobox gene HLXB9 is upregulated in a morphological subset of poorly differentiated hepatocellular carcinoma |
| Q87394000 | The influence on liver function after transcatheter arterial chemoembolization combined with percutaneous radiofrequency ablation in patients with hepatocellular carcinoma |
| Q33272872 | The progressive elevation of alpha fetoprotein for the diagnosis of hepatocellular carcinoma in patients with liver cirrhosis. |
| Q36409365 | The significance of cyclooxygenase-2 expression in human hepatocellular carcinoma |
| Q36065876 | Therapeutic polypeptides based on HBV core 18-27 epitope can induce CD8+ CTL-mediated cytotoxicity in HLA-A2+ human PBMCs |
| Q38376656 | Therapeutic priorities for solitary large hepatocellular carcinoma in a hepatitis B virus endemic area; an analysis of a nationwide cancer registry database |
| Q83423525 | Transarterial Chemoembolization for Hepatocellular Carcinoma |
| Q26797241 | Transarterial chemoembolization versus hepatic resection in hepatocellular carcinoma treatment: a meta-analysis |
| Q37128777 | Transcatheter arterial chemoembolization (TACE) with lipiodol to treat hepatocellular carcinoma: survey results from the TACE study group of Japan |
| Q91784365 | Transcatheter arterial chemoembolization combined with radiofrequency or microwave ablation for hepatocellular carcinoma: a review |
| Q50576318 | Treatment of chronic hepatitis C in non-responsive patients with pegylated interferon associated with ribavirin and thalidomide: report of six cases of total remission |
| Q53391931 | Trend of improving prognosis of hepatocellular carcinoma in clinical practice: an Italian in-field experience |
| Q37036012 | Triptolide Inhibits Invasion and Tumorigenesis of Hepatocellular Carcinoma MHCC-97H Cells Through NF-κB Signaling |
| Q34260503 | Validation of glypican-3-specific scFv isolated from paired display/secretory yeast display library |
| Q53270848 | Video-assisted thoracoscopic surgery for diaphragmatic defect complication with refractory hydrothorax related to radiofrequency ablation. |
| Q35617324 | Viral hepatitis C. |
| Q37281965 | Viral hepatitis markers in liver tissue in relation to serostatus in hepatocellular carcinoma. |
| Q37542814 | Viral hepatitis status does not affect survival in patients with hepatocellular carcinoma |
| Q33611696 | Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma |
| Q80554209 | [Molecular pathogenesis of hepatocellular carcinoma: new therapeutic approaches and predictive pathology] |
| Q35235798 | c-Met represents a potential therapeutic target for personalized treatment in hepatocellular carcinoma |
| Q92192259 | miR-194 inhibits liver cancer stem cell expansion by regulating RAC1 pathway |
Search more.